Mitchell Stephen Ray 4
4 · Vanda Pharmaceuticals Inc. · Filed May 21, 2024
Insider Transaction Report
Form 4
Mitchell Stephen Ray
Director
Transactions
- Award
Common Stock
2024-05-17+20,529→ 49,857 total - Award
Stock Option (right to buy)
2024-05-17+37,578→ 37,578 totalExercise: $5.48Exp: 2034-05-16→ Common Stock (37,578 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.